Prostate cancer is the most frequent malignant neoplasm in men and the second most common cancer death among American men. Screening for prostate cancer should include testing for prostate specific antigen (PSA). Digital rectal exam (DRE) may also be used as a complementary baseline test.
Refer to ARUP Laboratories’ test offerings below.
ARUP Laboratory Tests
Method
              Quantitative Chemiluminescent Immunoassay (CLIA)
Method
              Quantitative Electrochemiluminescent Immunoassay
Method
              Quantitative Electrochemiluminescent Immunoassay
Method
              Electrochemiluminescent Immunoassay (ECLIA)


